Other
Local Infiltration
0
Pipeline Programs↗
2
Active Trials↗
1
Companies Involved↗
Local Infiltration is an early-stage landscape with 0 programs across 1 company. The most active players are Pacira Pharmaceuticals, Inc.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
24
clinical trials
Completed17 · 71%
Terminated3 · 13%
Not yet recruiting1 · 4%
Unknown status1 · 4%
Recruiting1 · 4%
Withdrawn1 · 4%
Clinical Trials
Trial Activity
24 trials
Minimum Effective Dose of Incisional Local Infiltration Betamethasone for the Prevention of Pain After Spinal Surgery
Recruiting·—·N/A·NCT06785350·535 enrolled
Combination of Nerve Blocks and Local Infiltration Analgesia in Knee Arthroplasty
Not yet recruiting·—·Phase 4·NCT07350252·200 enrolled
Selective Tibial Nerve Block vs Local Infiltration Analgesia After Prothetic Knee Surgery
Completed·—·N/A·NCT03698006·60 enrolled
Local Infiltration Analgesia Following Unicompartmental Knee Arthroplasty
Completed·—·N/A·NCT00653926·40 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)